Optimize Allergy & Immunology Eligibility Verification Workflows

Klivira automates allergy & immunology eligibility verification, ensuring accurate patient coverage details are captured proactively for high-cost treatments like biologics and IVIG.

For Allergy & Immunology practices, verifying patient eligibility is a critical upstream step that prevents downstream claim denials, especially with the prevalence of complex and high-cost therapies. Manual processes are prone to errors, leading to stale data, misinterpretations, and missed prior authorization requirements. Klivira transforms this workflow into a precise, automated process.

The Unique Challenges of Eligibility Verification in Allergy & Immunology

Allergy & Immunology practices frequently manage patients requiring expensive specialty medications such as asthma biologics (e.g., Xolair, Dupixent, Nucala), IVIG/SCIG, and long-term allergen immunotherapy. These treatments often have specific benefit carve-outs, high copays, and strict medical necessity criteria, making accurate and timely eligibility verification paramount. Failure to confirm coverage details, including benefit category limits or deductible status, can lead to significant financial write-offs.

Manual Eligibility Workflows: A Source of Revenue Leakage

Traditional eligibility verification in Allergy & Immunology often involves front-office staff manually logging into various payer portals (e.g., Availity for multi-payer access, or payer-specific sites) or interpreting complex X12 271 responses from clearinghouses. This manual effort is time-consuming and error-prone. Common failure modes include stale eligibility data due to coverage changes between scheduling and service, misinterpretation of detailed benefit information, and missed prior authorization requirements for specific biologics or IVIG infusions, which directly impact claim adjudication.

Klivira's Automated Eligibility Verification for A&I

**Multi-Channel Querying:** Klivira submits X12 270 eligibility inquiries via your clearinghouse for EDI-capable payers and leverages FHIR Coverage resource retrieval for FHIR-conformant payers. For legacy-only payers, our system can automate payer-portal lookups.
**Normalized Benefit Data:** X12 271 responses and FHIR Coverage data are parsed into a uniform eligibility model, providing clear details on active status, plan type, in-network status, deductible, copay/coinsurance for service categories (e.g., specialty pharmacy, infusion services), and benefit-category limits.
**Real-Time & Batch Checks:** Eligibility checks are triggered at key points such as patient registration, appointment scheduling, and order entry. For high-cost A&I services scheduled in advance, Klivira automatically re-verifies eligibility closer to the date of service to catch mid-period coverage changes.
**EMR Integration & Write-Back:** Verified eligibility details are written back to your EMR, either as a structured Coverage resource update (where supported) or as a clear, structured note, ensuring clinical and administrative teams have current information.
**Proactive PA Workflow Gating:** When eligibility identifies a prior authorization requirement for a planned A&I service (e.g., an asthma biologic or IVIG infusion), Klivira's system can auto-initiate the PA workflow, closing the critical eligibility → PA detection loop and preventing PA-not-on-file denials.
**Benefit Exhaustion Tracking:** For A&I treatments with visit or cost caps, Klivira tracks running utilization against these limits, surfacing remaining benefits to prevent denials related to exhausted coverage.

Addressing A&I-Specific Failure Modes with Automation

Klivira's platform directly tackles the concrete failure modes that plague Allergy & Immunology practices. Our re-verification logic mitigates risks from stale eligibility data, crucial for long-term biologic therapies. The normalized eligibility model eliminates ambiguity from complex 271 responses, ensuring accurate understanding of coverage for IVIG or immunotherapy. Critically, automated PA workflow initiation, triggered by eligibility findings, prevents denials for high-cost A&I medications. We also automate secondary coverage identification and benefit-exhaustion tracking for visit-capped services, reducing uncompensated care.

Industry Standards and Data Exchange

Klivira adheres to industry standards for robust eligibility verification. We utilize the X12 270/271 transaction set for Health Care Eligibility/Benefit Inquiry and Response, the foundational EDI standard. For modern data exchange, we leverage the FHIR Coverage resource, which is central to workflows like Da Vinci CRD and PAS. Klivira can also consume eligibility details from payer-provided FHIR-based Patient Access APIs, as mandated by CMS-0057-F, ensuring comprehensive and standardized data retrieval.

Frequently asked questions

How does Klivira handle eligibility for high-cost biologics in Allergy & Immunology?

Klivira's system performs multi-channel eligibility queries to confirm coverage for biologics. It parses detailed benefit information to identify specific carve-outs, deductible status, and copay/coinsurance. Crucially, if eligibility indicates a prior authorization is required for the biologic, it can automatically initiate the PA workflow, preventing delays and denials.

Can Klivira verify eligibility for IVIG/SCIG infusions?

Yes, Klivira verifies eligibility for IVIG/SCIG infusions by querying payers via X12 270/271 or FHIR Coverage. It captures benefit details relevant to infusion services, including in-network status, remaining deductible, and any specific benefit-category limits or prior authorization requirements for these complex therapies.

What if a patient's coverage changes between scheduling an appointment and the date of service?

Klivira's re-verification logic addresses this. For high-cost Allergy & Immunology services scheduled in advance, the system can automatically re-check eligibility closer to the actual date of service, catching mid-period coverage changes and updating the EMR to prevent unexpected denials.

How does Klivira help prevent denials related to benefit exhaustion for A&I services?

For Allergy & Immunology services with visit or cost caps, Klivira tracks running utilization against these limits. This allows your practice to see the remaining benefits status proactively, preventing claims for services that would otherwise be denied due to exhausted coverage.

Does Klivira integrate eligibility verification with prior authorization workflows for A&I?

Absolutely. A key benefit for Allergy & Immunology practices is Klivira's ability to gate PA workflows with eligibility findings. If an eligibility check identifies a prior authorization requirement for a planned service, the system can automatically trigger the appropriate PA workflow, ensuring that authorizations are initiated promptly rather than being missed.